成人弥漫性神经胶质瘤分子神经病理学的不断发展的认识。
Evolving Insights into the Molecular Neuropathology of Diffuse Gliomas in Adults.
机构信息
Department of Pathology, VU University Medical Center, Brain Tumor Center Amsterdam, De Boelelaan 1117, Amsterdam 1081 HV, The Netherlands; The Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, Farmington, CT 06032, USA.
The Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, Farmington, CT 06032, USA.
出版信息
Neurol Clin. 2018 Aug;36(3):421-437. doi: 10.1016/j.ncl.2018.04.002.
Abstract
Recent advances in molecular analysis and genome sequencing have prompted a paradigm shift in neuropathology. This article discusses the discovery and clinical relevance of molecular biomarkers in diffuse gliomas in adults and how these biomarkers led to revision of the World Health Organization classification of these tumors. We relate progress in clinical classification to an overview of studies using molecular profiling to study gene expression and DNA methylation to categorize diffuse gliomas in adults and issues dealing with intratumoral heterogeneity. These efforts will refine the taxonomy of diffuse gliomas, facilitate selection of appropriate treatment regimens, and ultimately improve patient's lives.
摘要
近年来，分子分析和基因组测序的进展促使神经病理学发生了范式转变。本文讨论了成人弥漫性神经胶质瘤中分子生物标志物的发现及其临床意义，以及这些生物标志物如何导致这些肿瘤的世界卫生组织分类的修订。我们将临床分类的进展与使用分子谱分析研究基因表达和 DNA 甲基化以对成人弥漫性神经胶质瘤进行分类的研究概述以及与肿瘤内异质性相关的问题联系起来。这些努力将完善弥漫性神经胶质瘤的分类法，有助于选择合适的治疗方案，并最终改善患者的生活。
相似文献
1
Evolving Insights into the Molecular Neuropathology of Diffuse Gliomas in Adults.成人弥漫性神经胶质瘤分子神经病理学的不断发展的认识。
Neurol Clin. 2018 Aug;36(3):421-437. doi: 10.1016/j.ncl.2018.04.002.
2
Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation.通过对 2016 年 WHO 弥漫性胶质瘤分类进行以下四项指标的细化：EGFR 扩增、TERT 突变、PTEN 缺失和 MGMT 甲基化，获得的临床见解。
BMC Cancer. 2019 Oct 17;19(1):968. doi: 10.1186/s12885-019-6177-0.
3
DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.2016年世界卫生组织弥漫性胶质瘤分类亚型的DNA甲基化特征
Clin Epigenetics. 2017 Apr 4;9:32. doi: 10.1186/s13148-017-0331-9. eCollection 2017.
4
Characterization of gliomas: from morphology to molecules.胶质瘤的特征：从形态学到分子层面
Virchows Arch. 2017 Aug;471(2):257-269. doi: 10.1007/s00428-017-2181-4. Epub 2017 Jul 4.
5
Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.弥漫性胶质瘤的多维尺度分析：在具有预后相关分子亚型发现的 2016 年世界卫生组织分类系统中的应用。
Acta Neuropathol Commun. 2017 May 22;5(1):39. doi: 10.1186/s40478-017-0443-7.
6
RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion.基于 RNA 编辑的弥漫性神经胶质瘤分类：预测异柠檬酸脱氢酶突变和染色体 1p/19q 联合缺失。
BMC Bioinformatics. 2019 Dec 24;20(Suppl 19):659. doi: 10.1186/s12859-019-3236-0.
7
Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors.弥漫性星形细胞和少突胶质细胞瘤的综合诊断
Pathologe. 2019 Jun;40(Suppl 1):9-17. doi: 10.1007/s00292-019-0581-8.
8
Novel, improved grading system(s) for IDH-mutant astrocytic gliomas.新型改良的 IDH 突变型星形细胞瘤分级系统。
Acta Neuropathol. 2018 Jul;136(1):153-166. doi: 10.1007/s00401-018-1849-4. Epub 2018 Apr 23.
9
Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort.2016 年世界卫生组织弥漫性胶质瘤分类对法国 POLA 队列的预后影响。
Acta Neuropathol. 2016 Oct;132(4):625-34. doi: 10.1007/s00401-016-1611-8. Epub 2016 Aug 29.
10
Impending Impact of Molecular Pathology on Classifying Adult Diffuse Gliomas.分子病理学对成人弥漫性胶质瘤分类的潜在影响
Cancer Control. 2015 Apr;22(2):200-5. doi: 10.1177/107327481502200211.
引用本文的文献
1
Explainable Machine Learning Models for Glioma Subtype Classification and Survival Prediction.用于脑胶质瘤亚型分类和生存预测的可解释机器学习模型
Cancers (Basel). 2025 Aug 9;17(16):2614. doi: 10.3390/cancers17162614.
2
Exploring adult glioma through MRI: A review of publicly available datasets to guide efficient image analysis.通过磁共振成像探索成人胶质瘤：对公开可用数据集的综述以指导高效图像分析。
Neurooncol Adv. 2025 Jan 28;7(1):vdae197. doi: 10.1093/noajnl/vdae197. eCollection 2025 Jan-Dec.
3
MethylSPWNet and MethylCapsNet: Biologically Motivated Organization of DNAm Neural Networks, Inspired by Capsule Networks.甲基化SPW网络和甲基化胶囊网络：受胶囊网络启发的DNA甲基化神经网络的生物学驱动组织
NPJ Syst Biol Appl. 2021 Aug 20;7(1):33. doi: 10.1038/s41540-021-00193-7.
4
The Clinical Significance of Soluble Programmed Cell Death-Ligand 1 (sPD-L1) in Patients With Gliomas.可溶性程序性细胞死亡配体1（sPD-L1）在胶质瘤患者中的临床意义
Front Oncol. 2020 Jan 23;10:9. doi: 10.3389/fonc.2020.00009. eCollection 2020.
5
System-based approaches as prognostic tools for glioblastoma.基于系统的方法作为胶质母细胞瘤的预后工具。
BMC Cancer. 2019 Nov 12;19(1):1092. doi: 10.1186/s12885-019-6280-2.
6
Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastoma.对 34 个微阵列数据集的综合分析显示 CBX3 是胶质母细胞瘤的诊断和预后生物标志物。
J Transl Med. 2019 May 28;17(1):179. doi: 10.1186/s12967-019-1930-3.
本文引用的文献
1
The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space.胶质母细胞瘤疾病进展中的 DNA 甲基化图谱在时间和空间上表现出广泛的异质性。
Nat Med. 2018 Oct;24(10):1611-1624. doi: 10.1038/s41591-018-0156-x. Epub 2018 Aug 27.
2
A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence.在肿瘤复发过程中，一部分胶质母细胞瘤 CpG 岛甲基化表型中存在明显的 DNA 甲基化偏移。
Cell Rep. 2018 Apr 10;23(2):637-651. doi: 10.1016/j.celrep.2018.03.107.
3
Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy.人类胶质母细胞瘤的命运图谱揭示了一种不变的干细胞层级结构。
Nature. 2017 Sep 14;549(7671):227-232. doi: 10.1038/nature23666. Epub 2017 Aug 30.
4
Mutations in the promoter of the telomerase gene contribute to tumorigenesis by a two-step mechanism.端粒酶基因启动子中的突变通过两步机制促进肿瘤发生。
Science. 2017 Sep 29;357(6358):1416-1420. doi: 10.1126/science.aao0535. Epub 2017 Aug 17.
5
Grading of diffuse astrocytic gliomas: Broders, Kernohan, Zülch, the WHO… and Shakespeare.弥漫性星形细胞瘤的分级：布罗德斯、克诺汉、祖尔希、世界卫生组织……还有莎士比亚。
Acta Neuropathol. 2017 Oct;134(4):517-520. doi: 10.1007/s00401-017-1765-z. Epub 2017 Aug 11.
6
Epigenetic plasticity and the hallmarks of cancer.表观遗传可塑性与癌症特征
Science. 2017 Jul 21;357(6348). doi: 10.1126/science.aal2380.
7
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.胶质瘤内在基因表达亚型的肿瘤进化与微环境中的免疫变化相关。
Cancer Cell. 2017 Jul 10;32(1):42-56.e6. doi: 10.1016/j.ccell.2017.06.003.
8
Dual-Genotype Diffuse Low-Grade Glioma: Is It Really Time to Abandon Oligoastrocytoma As a Distinct Entity?双基因型弥漫性低级别胶质瘤：真的是时候摒弃少突星形细胞瘤这一独立实体了吗？
J Neuropathol Exp Neurol. 2017 May 1;76(5):342-346. doi: 10.1093/jnen/nlx024.
9
Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq.通过单细胞RNA测序解析IDH突变型胶质瘤中的遗传学、谱系和微环境
Science. 2017 Mar 31;355(6332). doi: 10.1126/science.aai8478.
10
Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma.用于预测1p19q共缺失弥漫性胶质瘤患者预后的多基因特征
Neuro Oncol. 2017 Jun 1;19(6):786-795. doi: 10.1093/neuonc/now285.
Zotero 插件